Oxra L 10mg/5mg Tablet 10s

Oxra L 10mg/5mg Tablet 10s operates by inhibiting the retention of glucose in the kidneys, which leads to more sugar secretion through urine. This effectively decreases the blood sugar levels by diminishing the glucose reabsorption into the bloodstream. Conversely, Linagliptin obstructs an enzyme known as DPP-4. This particular enzyme typically disintegrates hormones that escalate insulin and reduce glucagon, both are crucial for blood sugar regulation. Thus, in simplified language, Dapagliflozin prompts the elimination of more sugar via urination, while Linagliptin optimizes the blood sugar management of the body by adjusting hormone levels.

• Adhere to your physician's instructions for this medication, utilizing it in the stipulated quantity and timeframe.
• This medication can be consumed with or without meals, but sustaining a regular schedule daily is suggested for optimal benefits.
• Ingest the pharmaceutical fully; refrain from gnawing, pulverizing, or fragmenting it.

• Dapagliflozin can lead to increased urine production, which may result in dehydration It''s important to maintain adequate fluid intake, especially in situations that can cause fluid loss, such as diarrhea, vomiting, or excessive sweating.
• Linagliptin is primarily metabolized in the liver Individuals with liver impairment may require dose adjustments Combining it with dapagliflozin may necessitate close monitoring of liver function.

• Manages high blood glucose levels.
• Essential for diabetes management.
• Prevents complications like kidney damage.
• Reduces the risk of blindness.
• Lowers the chance of cardiovascular events.

• Vaginal yeast infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection